Antimicrobial resistance is a growing concern for public and animal health. Threats to public health could come from the transfer of pathogens from animals to people via indirect contact such as through food or by direct contact with animals. In addition, concern has been raised for the potential transfer of resistance determinants from animals to humans through commensal bacterial flora such as Escherichia coli. Isolates of E. coli and Salmonella spp. from dairy cows on farms in 21 states were evaluated for resistance to a panel of 16 antimicrobial drugs. Resistance patterns for E. coli were compared to those of Salmonella spp. when they were isolated concurrently on the same farm or from the same fecal sample. Overall, most of the E. coli isolates (85.3%) and Salmonella spp. isolates (87.2%) were susceptible to all antimicrobials in the panel. The resistance profiles for E. coli with and without concurrent isolation of Salmonella were comparable with the exception of tetracycline resistance, which was more common among the E. coli isolated with Salmonella spp. The resistance patterns for E. coli and Salmonella spp. isolated concurrently were not significantly different for any of the antimicrobials evaluated. The data from this study demonstrate that the majority of commensal E. coli and Salmonella spp. recovered from feces of dairy cows harbored no resistance to a broad range of antimicrobial drugs. Further studies are indicated to better understand the factors that influence the frequency of resistance in commensal E. coli and Salmonella spp. on dairy operations.
Introduction

G
rowing concern for changing patterns of antimicrobial resistance has resulted in the initiation of surveillance programs worldwide to better understand the resistance trends (CIPARS, 2003; DANMAP, 2004; EARSS, 2005; NARMS, 2006a; SVA, 2005; Turner et al., 1999) . Historically, much of the interest has focused on pathogenic bacteria; more recently, the role of commensal organisms as a reservoir or vehicle to transfer resistance genes to more harmful, pathogenic bacteria has been postulated (Bartoloni et al., 2006; Blake et al., 2003; Courvalin, 2005; Dyer et al., 2006; Moubareck et al., 2003) . One such mechanism is the transfer of antimicrobial resistant plasmids between Escherichia coli and Salmonella spp. (DeFrancesco et al., 2004) . Of concern is the foodborne transmission of resistant pathogenic and commensal organisms to people (Cronquist et al., 2006; Holmberg et al., 1984; Mølbak et al., 1999; Spika et al., 1987; Villar et al., 1999; Zansky et al., 2002) , some of which may originate with animals. The issue has been recognized as serious by the World Organization of Animal Health (OIE) (OIE, 2001) and the World Health Organization (WHO, 2000) . A better understanding of what may happen at the molecular level when these bacteria have intimate contact in the gut or environment requires a deeper understanding of the ecology of pathogenic and commensal organisms, and the antimicrobial resistance trends in each of the respective populations.
Salmonella spp. can cause illness in both animal and human populations. Each year an estimated 1,412,500 human illnesses are attributed to Salmonella spp., and it is estimated that 95% of these are of foodborne origin (Mead et al., 1999) . Salmonella spp. are also responsible for a substantial number of animal illnesses annually; however, the biology of the many different serotypes is diverse and patterns of infection vary greatly within and among such factors as serotype, animal species, geography, climate, herd size, and management practices, making characterization and control of the disease difficult (Cobbold et al., 2006; Radostits et al., 2000) .
Microbiological and clinical data indicate that antimicrobial drug resistance complicates, and can jeopardize, treatment of serious bacterial infections in both animals and humans (Harada et al., 2006; Kalpana et al., 2001; Nelson et al., 2004; WHO, 2002) . The extent and temporal trends of resistance of human and animal origin isolates of Salmonella spp. and E. coli in the United States have been monitored by NARMS since 1996 , respectively (NARMS, 2006a , 2006b . A recent national study investigating the prevalence of Salmonella spp. and their resistance profiles from U.S. dairy cows found Salmonella spp. in 7.3% (269=3079) of samples collected with 83.0% of those isolates pan-susceptible to a panel of 16 antimicrobials (Blau et al., 2005) .
This study was intended to improve the understanding of the ecology of both Salmonella spp. and E. coli (a commensal organism), and to improve understanding of the antimicrobial resistance of each organism on dairy operations, particularly when they can be recovered from the same sample or operation. The four objectives of the study were, first, to describe the prevalence and patterns of antimicrobial resistance in isolates of E. coli from dairy cattle fecal samples; second, to describe antimicrobial resistance of a subpopulation of E. coli where Salmonella spp. were identified in the same fecal sample; third, to evaluate the similarity of antimicrobial resistance prevalence and patterns for isolates of E. coli and Salmonella spp. in the same fecal sample; and fourth, to evaluate the similarities of antimicrobial resistance patterns among E. coli and Salmonella spp. from the same operation, but not necessarily from the same sample.
Materials and Methods
Study population and sample collection
A stratified random sample of 3876 dairies was chosen from the United States Department of Agriculture (USDA) National Agricultural Statistics Service's list frame for each of 21 selected states. The states were allocated to four regions for analysis including West (California, Colorado, Idaho, New Mexico, Texas, and Washington), Midwest (Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Ohio, and Wisconsin), Northeast (New York, Pennsylvania, and Vermont), and Southeast (Florida, Kentucky, Tennessee, and Virginia). This sample was selected to represent 85.5% of U.S. dairy cows and was the basis for participation in the USDA's Animal and Plant Health Inspection Service's National Animal Health Monitoring System (NAHMS) Dairy 2002 study. Participation in the first phase of the study included 2461 dairy producers, of which 1013 participated in the second phase, which included on-farm visits and collection of biological samples (USDA, 2003) . Due to limited laboratory capacity, a convenience sample of 97 of these dairies, approximately five operations per state, was selected for fecal sampling based on the operations' perceived risk of having and transmitting Mycobacterium avium subsp. paratuberculosis. Factors used to classify herds included 1) number of dairy cows, 2) how soon calves were separated from their dam, 3) whether pooled colostrum was fed, 4) the percentage of dairy cows that had diarrhea for more than 48 hours, 5) whether maternity housing was separate from lactating cow housing, 6) how many replacements were brought onto the operation during 2001, and 7) whether the operation required Johne's disease testing for purchased cattle. Perceived low-and high-risk herds were identified from each participating state, with herds stratified into below and above median herd size for the state. Between four and six operations were selected in each participating state. Two operations were chosen from the low-risk group-one above and one below the median herd size for the state. Three operations were chosen from the highrisk group-either two above median herd size and one below median herd size, or vice versa. More details on the herd selection are available in Lombard et al. (2006) .
Dairies were visited between March 27 and September 25, 2002; data were collected on herd and animal-health management factors and up to 40 fecal samples were collected from a convenience sample of cows 2 years of age or older via rectal retrieval. A separate glove was used to collect each fecal sample to avoid crosscontamination during sampling. Samples were placed in Whirl-Pak Ò bags (NASCO, Fort Atkinson, WI) and shipped on ice to the USDA Agricultural Research Service Bacterial Epidemiology and Antimicrobial Resistance Research Unit in Athens, GA, for culturing and antimicrobial susceptibility testing.
Bacteriologic culture
Samples were cultured for Salmonella spp. as previously described (Wells et al., 2001) . Briefly, approximately 1 g of feces from each sample was placed into GN Hajna broth and tetrathionate broth, which were incubated at 378C for 24 and 48 hours, respectively. Following primary enrichments, culture aliquots (100 mL) were transferred into Rappaport R-10 medium for secondary enrichment. In each case the Rappaport R-10 medium was incubated overnight at 378C then streaked onto brilliant green agar with sulfadiazine and XLT-4 plates. All plates were incubated overnight at 378C. As many as four colonies from each sample, each having the typical appearance of Salmonella spp., were inoculated into triple sugar iron and lysine iron agar slants. All slants were incubated overnight at 378C. Presumptive positive isolates were serogrouped using serogroup-specific typing sera (Difco Laboratories, Detroit, MI) and sent to the National Veterinary Services Laboratories in Ames, IA, for serotyping.
The first 15 samples per operation, of the set of up to 40 samples, were cultured for E. coli by inoculating 100-mL aliquots of fecal dilutions (1:9 w=v, in sterile phosphate-buffered saline) onto CHROMagar ECC TM (Hardy Diagnostics, Santa Maria, CA) and streaking for isolation. The media were incubated for 18-24 hours at 428C. One well-isolated indole reaction positive blue-green colony from each sample, which is characteristic of E. coli, was transferred onto nutrient agar (Difco Laboratories) slants for short-term storage at room temperature prior to further characterization.
Antimicrobial susceptibility testing methods
All E. coli and Salmonella spp. isolates were evaluated for antimicrobial susceptibility to a custom-made panel of 16 antimicrobials. All isolates were tested using broth microdilution and the semi-automated SensititreÔ System as per manufacturer's instructions (TREK Diagnostic Systems, Inc., Cleveland, OH). The antimicrobial drugs tested were amikacin (Ami), amoxicillin= clavulanic acid (Amo), ampicillin (Amp), cefoxitin (Fox), ceftiofur (Tio), ceftriaxone (Axo), cephalothin (Cep), chloramphenicol (Chl), ciprofloxacin (Cip), gentamicin (Gen), kanamycin (Kan), nalidixic acid (Nal), streptomycin (Str), sulfamethoxazole (Sul), tetracycline (Tet), and trimethoprim=sulfamethoxazole (Tri). Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Enterococcus faecalis ATCC 29212 were included as control strains for the antimicrobial susceptibility testing. The minimum inhibitory concentration (MIC) for each isolate was determined; each isolate was classified as susceptible, intermediate, or resistant, according to guidelines published by the Clinical and Laboratory Standards Institute (CLSI) (formerly known as National Committee on Clinical Laboratory Standards) for broth microdilution susceptibility testing, when available (CLSI, 2002) . Otherwise, breakpoint interpretations were determined as reported for the NARMS program (NARMS, 2007) . For all analyses, isolates with antimicrobial susceptibility categorized as intermediate were recategorized as susceptible.
DRUG RESISTANCE FROM DAIRY COW ISOLATES
Isolate subgroups
This study evaluated E. coli isolates with (ECþS) and without (ECÀS) concurrent isolation of Salmonella spp. from the same sample, or at the same operation. The Salmonella spp. isolates referred to in this study include only the subgroup of isolates found in the same samples, or at the same operations, as the E. coli isolates.
Statistical analysis
All isolate-level analyses were performed using statistical software (SUDAAN, Version 9.0.1, RTI International, Research Triangle Park, NC; STATA, Version 8.2, StataCorp LP, College Station, TX) that accounts for the clustering of isolates on farms. Both SUDAAN and STATA account for the clustering by estimating variances using the Taylor series linearization method. For operation-level analyses, a herd was considered ''positive'' for E. coli or Salmonella spp. when at least one fecal isolate was positive; similarly a herd was considered ''resistant'' to a specific antimicrobial if at least one isolate from that herd was resistant to that antimicrobial.
The distributions of isolates of ECþS and ECÀS across operation-level variables, determined a priori, were compared descriptively because E. coli was ubiquitous and the distribution of all Salmonella isolates has been previously reported. To evaluate the prevalence of resistance to the 16 antimicrobial drugs among E. coli isolates in relation to the presence of Salmonella spp., univariable analyses also were performed using log-likelihood chi-square. These comparisons were performed at the isolate level. Variables with p < 0.25 were eligible to enter a logistic regression model. Variables with p < 0.05 using a backwards elimination method were kept in the model. To determine whether there were significant differences in the prevalence of resistance of E. coli to the individual antimicrobials in relation to the resistance of Salmonella spp. found in the same sample, conditional logistic regression was performed (STATA, Version 8.2, StataCorp LP, College Station, TX). Similarities in resistance of the ECþS and Salmonella spp. isolates were evaluated using a Wald chi-square test statistic adjusted for matched isolates. Operation-level comparisons of the collective antimicrobial resistance profile from all E. coli isolates to the collective resistance profile from all Salmonella spp. isolates recovered from the same operation were performed using logistic regression models (SAS, Version 9.1, SAS Institute Inc., Cary, NC). For all tests, a difference was considered significant using a critical alpha value of 0.05.
Results
A total of 1450 fecal samples from 97 operations were cultured for E. coli and Salmonella; 32.8% of the samples tested were from dairy operations classified as small (<100 cows), 41.3% were from medium operations (100-499 cows), and 25.9% were from large operations (500 or more cows). For the purpose of analysis, the United States was divided into four regionsWest, Midwest, Northeast, and Southeast-with 29.0%, 41.1%, 15.5%, and 14.4% of the samples originating from each region, respectively.
Escherichia coli was isolated from a total of 1389 (95.8%) of the samples and all of the 97 (100.0%) operations. The prevalence for all 294 Salmonella spp. isolates identified in the NAHMS Dairy 2002 study are described in a previous publication (Blau et al., 2005) . Salmonella spp. was isolated from 94 (6.8%) of the fecal samples from which E. coli was isolated (ECþS), representing 30.9% (30=97) of all operations sampled. The samples containing both bacteria were most commonly from the West (43=94), in herds with 500 cows or more (51=94), and from herds where the predominant method of manure handling was dry-lot scraping (31=94) ( Table 1 ).
Antimicrobial susceptibility, isolate level
Overall, 85.9% of the ECÀS and 77.7% of the ECþS were susceptible to all of the antimicrobial agents tested ( p ¼ 0.092; Table 2 ). All ECÀS and ECþS isolates were susceptible to amikacin, ceftriaxone, and ciprofloxacin. Of the 1295 ECÀS isolates, 8.3% were resistant to only one antimicrobial drug and 6.0% were resistant to $2 antimicrobials. Of the 94 ECþS isolates, 10.6% were resistant to only one antimicrobial drug and 11.7% were resistant to $2 antimicrobials. Among resistant isolates in both subgroups, resistance to tetracycline was most common (10.0% of ECÀS and 20.2% of ECþS) and greater than 3% of the isolates were resistant to cephalothin, streptomycin, and sulfamethoxazole. The percentage resistance to ampicillin and tetracycline was approximately twofold greater among the ECþS isolates (Table 2) . Only ampicillin, ceftiofur, and tetracycline met the p < 0.25 criteria for entering the logistic model. The final logistic model demonstrated differences between the E. coli subgroups were significant for tetracycline resistance only ( p ¼ 0.018).
The eight most common resistance phenotypes for the ECÀS isolates were also found among the top 10 phenotypes for the ECþS isolates (Table 3) . When resistance was evident, it involved streptomycin, sulfamethoxazole, and tetracycline either individually or together, or cephalothin alone.
Among the E. coli and Salmonella spp. isolates identified in the same fecal sample, Salmonella spp. isolates were either pan-susceptible (82=94, 87.2%), resistant to tetracycline alone (7=94, 7.4%), or were multiresistant to eight antimicrobials or more (5=94, 5.4%).
The majority of ECþS isolates were pansusceptible (73=94, 77.7%), nine were resistant to tetracycline alone (9.6%), and 10 of the remaining 12 were resistant to #3 antimicrobials (10.6%) ( Table 3 ). All isolates of E. coli and Salmonella from the same fecal sample were susceptible to amikacin, ceftriaxone, ciprofloxacin, nalidixic acid, and trimethoprim=sulfamethoxazole. Resistance to tetracycline (alone or within a multiresistance phenotype) was most common in both the ECþS (20.2%) and in the Salmonella spp. isolates (12.8%). All p values for comparing differences in the prevalence of resistance for ECþS and Salmonella for any of the individual antimicrobials were greater than 0.05 ( p ¼ 0.129 to 0.796) ( Table 2 ). Consequently, none of the variables were able to remain in a multivariable model.
Antimicrobial susceptibility, operation level
At the operation level, it was common for one or more of the E. coli isolates to be resistant to one or more antimicrobial drugs (Table 4) . Consequently 77.6% of the 67 operations with at least one E. coli positive fecal isolate, but without any Salmonella spp. isolations, and 76.7% of the 30 operations with both E. coli and Salmonella spp. had $1 E. coli isolates resistant to one or more of the antimicrobial drugs. All E. coli isolates from all operations, regardless of Salmonella status, were susceptible to amikacin, ceftriaxone, and ciprofloxacin. For E. coli, resistance to tetracycline was most common, regardless of concurrent isolation of Salmonella; 73.3% of the operations with, and 58.2% without, Salmonella spp. had tetracycline-resistant isolates. Following tetracycline, antimicrobial resistance was most common for cephalothin, streptomycin, and sulfamethoxazole for both subgroups of E. coli (Table 4) . For all antimicrobials, with the exception of kanamycin, the prevalence of resistance in E. coli tended to be higher for operations with Salmonella spp. present than those with Salmonella absent. Seven antimicrobials (Amo, Amp, Tio, Cep, Str, Tet, and Tri) met the p ¼ 0.25 screening cutoff. However, the multivariate model examining the difference between the two subgroups included only ceftiofur ( p ¼ 0.024). Log-likelihood chi-square statistic p value met the screening criteria ( p < 0.25) comparing operations with one or more resistant E. coli isolate with, compared to without, concurrent identification of Salmonella spp. at the same operation. c Log-likelihood chi-square statistic p-value met the screening criteria ( p < 0.25) comparing operations with one or more resistant isolates of E. coli and one or more resistant isolates of Salmonella to the individual antimicrobial.
In the 30 operations where E. coli and Salmonella spp. were both identified, Salmonella isolates were pan-susceptible on 21 (70.0%) operations (Table 4) . At least one isolate of both E. coli and Salmonella spp. was resistant to one or more antimicrobial drugs on eight of the operations (26.7%). On five of these eight operations one Salmonella isolate was multiresistant to at least nine antimicrobials (Amo, Amp, Fox, Tio, Cep, Chl, Str, Sul, and Tet; Operations A, B, F, G, and H; Table 5 ). The remaining three operations had one or more Salmonella isolates resistant to no 
Discussion
The emergence and dissemination of antimicrobial resistance is an important issue in public health, animal health, and food safety. Much of the data available on antimicrobial resistance in E. coli and Salmonella spp. isolates from dairy operations are from clinical cases or selected samples based on factors such as previous history of salmonellosis or current or previous antimicrobial use. Resistance phenotypes from clinical cases may not be characteristic of isolates from healthy dairy cattle. In contrast, herds and animals for the current study were not selected based on Salmonella status. Also, few studies have addressed the concern of transferring antimicrobial resistance between bacterial species; Blake et al. (2003) , Winokur et al. (2001) , and Zhao et al. (2003) , among others, have confirmed the biologic plausibility of this proposed mechanism in a laboratory. This is one of the first epidemiologic studies of dairies to evaluate the antimicrobial resistance of E. coli isolates with and without concurrent identification of Salmonella spp. in the same fecal sample or the same herd.
The prevalence of E. coli resistance to individual antimicrobials from the fecal isolates of adult dairy cows in the current study were consistent with findings from other studies of nonclinical isolates from adult dairy cattle (DeFrancesco et al., 2004; Sato et al., 2005) . The prevalence of resistance in the subgroup of 94 Salmonella spp. isolates evaluated in this paper adequately represent the distribution of Salmonella resistance found in all 294 isolates reported earlier (Blau et al., 2005) , with the exception of streptomycin; resistance to streptomycin was evident in 9.5% of all 294 isolates (Blau et al., 2005) but in only 5.3% of the subgroup of isolates evaluated in this paper ( p ¼ 0.218).
There were varying results in the comparisons of resistance to the individual antimicrobials at the isolate and operation level; this is, in part, due to low prevalence of resistance at the isolate level in combination with a relatively small sample size. For example, in order to detect a difference between two resistance prevalences at the 5% significance level with 80% power, where the lowest prevalence is 5.0%, a sample size of 159 or 473 would be needed in each group to detect a 10.0% or 5.0% difference, respectively in prevalence, assuming a random sample of isolates (no clustering). With the exception of tetracycline, the isolate-level prevalence of resistance to the individual antimicrobials ranged from 0.0% to 6.4%, and the greatest observed difference in percent resistance between the groups being compared was only 3.2. These factors, along with the small sample size of the subgroup of ECþS (n ¼ 94) limited the ability to detect significant differences between isolate-level prevalences in different groups. At the operation level, all isolates from the same operation were combined into a single response. This reduced the sample size to 30 but the consolidation resulted in increasing both the magnitude of the proportions being compared and the difference between the two proportions, thus allowing for significant differences to be detected between the two subgroups.
The comparisons of antimicrobial drug resistance in this study were all based on resistance phenotypes determined by the application of breakpoints to MIC values, with organisms characterized as either resistant, or not resistant, to the individual antimicrobials. This is likely a more coarse measure (less specific) than comparison based on genotype. For example, there are many genes (25þ) that convey tetracycline resistance by way of three different mechanisms (Mascaretti, 2003; Prescott, 2000; Roberts, 1994) . If the comparisons were based on the specific genes and the genetic structure (gene location and location in a mobile element) we would have a more accurate evaluation of whether there was the potential for sharing of genes between the two populations. The analysis involving operation-level variables assessed herd-level prevalence of resistance to the individual antimicrobials. Herdlevel prevalence is a comprehensive measure of the ecology of bacterial shedding, antimicrobial resistance, and the commonality of resistance phenotypes. This measure is relevant because 70.1% of the samples came from animals housed in multiple-animal pens, and all samples from individual animals were collected on the same day. However, this may not be representative of the bacterial population existing in the intestinal tract of the animal at the time of sampling, as shedding can be sporadic (Smith, 1996) . In addition, the operation-level findings should be interpreted with caution in that the analyses did not account for the intensity of resistance (number of resistant isolates per operation); therefore an operation may have had one resistant isolate or all resistant isolates. By the same token, assessing resistance for one generic E. coli strain per sample only provides information for that isolate and not necessarily for the entire generic E. coli population, which may be quite heterogenous.
When interpreting the findings of this study, some limitations should be acknowledged. First, the analyses compared the prevalence of resistance to individual antimicrobials, yet many of the isolates demonstrated multiresistance. Many of the unique resistance patterns were only present in a small number of isolates (low prevalence and associated sample size); therefore, comparisons of multiresistance isolates were not possible. Secondly, one should generalize the results from this study with caution. The results were based on a one-time sampling and should be interpreted as the prevalence at a single point in time. Also, a selection bias may have existed if the E. coli and Salmonella isolates identified were not representative of the bacterial population and=or resistance phenotypes in the animal or in the herd; up to 40 samples were collected per farm with the goal of capturing an adequate representation of the bacteria present. Analyses concerning the prevalence of antimicrobial resistance are affected by the selection of susceptibility breakpoints and dilution panel ranges. The dichotomization of data by these breakpoints can result in the loss of information on incremental changes in susceptibility when they occur. For all resistant isolates in the current study we evaluated the range of MIC values, but the numbers of isolates were too small for practical analyses. We did not assess the ability of any resistance attribute to be transferred between isolates, nor did we screen for the presence of integrons and plasmids. Further characterization of these isolates is warranted. Herds for this study were selected based on the perceived risk of having and transmitting Mycobacterium avium subsp. paratuberculosis. This selection method could have affected the outcomes for this study; however, the percentage of Salmonella-positive herds was not significantly different between the low and high risk herds.
There are several strengths of this study. Even though these dairy operations were based on a convenience subsample from a stratified probability sample of dairies across the United States, they reflect the diversity of regions and herd sizes present in the U.S. dairy population (USDA, 2002) . All biologic sample collections were performed using standardized methods and all bacteriologic culture and sensitivity methods were performed at a single laboratory, also using standardized methods. Lastly, all survey and biologic data collected were complete, ensuring total enumeration of the study population.
Because antimicrobial resistance is a threat to public health, animal health, and food safety, more research is needed to minimize the propagation of resistance through a greater understanding of the distribution of both pathogenic and nonpathogenic bacteria, their resistance profiles, and their abilities to, and mechanisms for, transferring resistance. Although the low prevalence of resistance among the generic E. coli and Salmonella spp. isolates limited the statistical power in this epidemiologic study, the results will be available as baselines for future comparative studies to evaluate antimicrobial resistance trends. Future studies should consider controlling for the known or potential confounding factors of antimicrobial resistance in their study design, comparing resistance by Salmonella serotype, and increasing the numbers of participating farms and samples collected. These considerations would allow for a more thorough investigation of the issue, including evaluation of the antimicrobial resistance trends on a multivariable level.
Conclusions
The results of this study show that most of the commensal E. coli and Salmonella spp. isolated from feces of dairy cows are susceptible to a broad array of antimicrobial drugs. The resistance profile of commensal E. coli tended to be the same whether or not Salmonella spp. were isolated concurrently from the same sample. When E. coli and Salmonella spp. were isolated concurrently the resistance profile tended to be similar, but not necessarily identical. More work is indicated to elucidate the factors that select for resistance among both commensal E. coli and Salmonella spp. in dairy cow populations.
